{
  "ticker": "OSL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968634",
  "id": "02968634",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250711",
  "time": "1359",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250711/pdf/06lqc8q78jwtty.pdf",
  "summary": "**Summary:**  \n- **Initial Director\u2019s Interest Notice (Appendix 3X)** for Oncosil Medical Limited (ASX: OSL).  \n- **Director:** Thomas Duthy (appointed 11 July 2025).  \n- **Material Disclosure:** No securities or relevant interests held by the director at the time of filing.  \n\n**Conclusion:** No material trading or capital markets impact identified.",
  "usage": {
    "prompt_tokens": 734,
    "completion_tokens": 85,
    "total_tokens": 819,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-11T04:52:35.352127"
}